Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.9606
+0.0104 (1.09%)
Sep 11, 2026, 4:00 PM EDT - Market closed

CELZ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6746514
Market Cap Growth
-28.84%69.59%-36.61%18.77%-61.64%-16.41%
Enterprise Value
-21-2-6-1714
Last Close Price
0.961.962.314.613.8122.10

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----0.73
PS Ratio
2110.941141.59367.17707.9660.55159.35
PB Ratio
0.720.910.640.620.341.37
P/TBV Ratio
0.760.960.700.640.351.44

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-248.04---163.74

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.000.00
Net Debt / Equity Ratio
-1.02-0.96-0.93-0.96-1.16-1.05
Net Debt / EBITDA Ratio
1.441.201.051.811.813.53
Asset Turnover
00.000.000.000.010.02
Inventory Turnover
--1.000.432.71-
Quick Ratio
12.6525.3018.1326.895.5410.21
Current Ratio
12.9125.9718.7327.665.6410.22
Return on Equity (ROE)
-77.88%-86.47%-65.85%-40.34%-77.78%-
Return on Assets (ROA)
-47.32%-53.03%-41.30%-23.49%-42.05%-32.60%
Return on Capital Employed (ROCE)
-71.90%-81.60%-90.60%-54.30%-64.60%-30.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-95.39%-87.52%-136.01%-82.97%-189.10%137.39%
Buyback Yield / Dilution
-61.50%-60.95%-5.17%-28.76%-236.51%-460.63%
SEC Filings: 10-K · 10-Q